Altered chromatin conformation in Alzheimer's disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Chromatin structure, specifically the balance between heterochromatin and euchromatin, plays a crucial role in gene regulation.
• Alterations in chromatin organization are implicated in various neurodegenerative diseases.

Purpose of the Study:

• To investigate the relationship between chromatin composition and Alzheimer's disease.
• To quantify the differences in euchromatin and heterochromatin content in human brains affected by Alzheimer's disease.

Main Methods:

• Chromatin was isolated from human brain samples, including those from Alzheimer's patients and controls.
• Chromatin was fractionated into heterochromatin and euchromatin components.
• RNA synthesis capability of euchromatin fractions was assessed using a bacterial RNA polymerase probe.

Main Results:

• Euchromatin fractions, capable of RNA synthesis, constituted approximately 75% of total DNA in control brains and brains with other neurological conditions.
• Brains with advanced Alzheimer's disease showed a reduced euchromatin content, averaging 55% of total DNA.
• Heterochromatization was observed in both neuronal and glial cells, indicating widespread chromatin changes.

Conclusions:

• Alzheimer's disease is associated with a significant decrease in euchromatin, suggesting widespread gene silencing.
• The observed heterochromatization in both neurons and glia points to a fundamental alteration in protein metabolism in Alzheimer's disease.
• These findings highlight chromatin remodeling as a key pathological feature of Alzheimer's disease.